DILUTE PASSAGE PROMOTES EXPRESSION OF GENETIC AND PHENOTYPIC VARIANTS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 IN CELL-CULTURE

被引:0
|
作者
SANCHEZPALOMINO, S
ROJAS, JM
MARTINEZ, MA
FENYO, EM
NAJERA, R
DOMINGO, E
LOPEZGALINDEZ, C
机构
[1] INST SALUD CARLOS III,CTR BIOL CELULAR & RETROVIRUS,E-28220 MADRID,SPAIN
[2] UNIV AUTONOMA MADRID,CSIC,CTR BIOL MOLEC,E-28049 MADRID,SPAIN
[3] KAROLINSKA INST,DEPT VIROL,S-10401 STOCKHOLM 60,SWEDEN
关键词
D O I
暂无
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
We have studied the extent of genetic and phenotypic diversification of human immunodeficiency virus type 1 (HIV-1) upon 15 serial passages of clonal viral populations in MT-4 cell cultures. Several genetic and phenotypic modifications previously noted during evolution of HIV-1 in infected humans were also observed upon passages of the virus in cell culture. Notably, the transition from non-syncytium-inducing to syncytium-inducing phenotype (previously observed during disease progression) and fixation of amino acid substitutions at the main antigenic loop V3 of gp120 were observed in the course of replication of the virus in MT-4 cell cultures in the absence of immune selection. Interestingly, most genetic and phenotypic alterations occurred upon passage of the virus at a low multiplicity of infection (0.001 infectious particles per cell) rather than at a higher multiplicity of infection (0.1 infectious particles per cell). The degree of genetic diversification attained by HIV-1, estimated by the RNase A mismatch cleavage method and by nucleotide sequencing, is of about 0.03% of genomic sites mutated after 15 serial passages. This value is not significantly different from previous estimates for foot-and-mouth disease virus when subjected to a similar process and analysis. We conclude that several genetic and phenotypic modifications of HIV-1 previously observed in vivo occur also in the constant environment provided by a cell culture system. Dilute passage promotes in a highly significant way the expression of deviant HIV-1 genomes.
引用
收藏
页码:2938 / 2943
页数:6
相关论文
共 50 条
  • [1] VARIANTS OF THE HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    TOURNIER, JN
    VERRIER, B
    BIRON, FF
    MANDRAND, B
    PEYRAMOND, D
    MEDECINE ET MALADIES INFECTIEUSES, 1995, 25 (05): : 709 - 715
  • [2] HUMAN HERPESVIRUS-6 INHIBITS HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 REPLICATION IN CELL-CULTURE
    LEVY, JA
    LANDAY, A
    LENNETTE, ET
    JOURNAL OF CLINICAL MICROBIOLOGY, 1990, 28 (10) : 2362 - 2364
  • [3] ZIDOVUDINE-RESISTANT HUMAN-IMMUNODEFICIENCY-VIRUS SELECTED BY PASSAGE IN CELL-CULTURE
    LARDER, BA
    COATES, KE
    KEMP, SD
    JOURNAL OF VIROLOGY, 1991, 65 (10) : 5232 - 5236
  • [4] HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 ANTIGEN AND CULTURE ASSAYS
    JACKSON, JB
    ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE, 1990, 114 (03) : 249 - 253
  • [5] STIMULATION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 EXPRESSION BY CERAMIDE
    PAPP, B
    ZHANG, DZ
    GROOPMAN, JE
    BYRN, RA
    AIDS RESEARCH AND HUMAN RETROVIRUSES, 1994, 10 (07) : 775 - 780
  • [6] MORPHOGENESIS OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    CHATTERJEE, S
    BASAK, S
    KHAN, NC
    PATHOBIOLOGY, 1992, 60 (04) : 181 - 186
  • [7] RADIOSENSITIVITY OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    CONWAY, B
    TOMFORD, WW
    CLINICAL INFECTIOUS DISEASES, 1992, 14 (04) : 978 - 979
  • [8] INFECTION WITH HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    PEDERSEN, C
    DANISH MEDICAL BULLETIN, 1994, 41 (01) : 12 - 22
  • [9] INHIBITION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1 EXPRESSION BY A HAIRPIN RIBOZYME
    OJWANG, JO
    HAMPEL, A
    LOONEY, DJ
    WONGSTAAL, F
    RAPPAPORT, J
    PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1992, 89 (22) : 10802 - 10806
  • [10] A QUANTITATIVE PROCEDURE FOR MONITORING EXPRESSION OF HUMAN-IMMUNODEFICIENCY-VIRUS TYPE-1
    COMAR, M
    MARZIO, G
    DAGARO, P
    GIACCA, M
    MINERVA BIOTECNOLOGICA, 1995, 7 (02) : 137 - 145